Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Active, not recruiting"
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (2.334)
1
Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin : A Phase I Trial of AT13387 in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) Receiving Concurrent Radiation and Cisplatin
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor : A Phase I Trial of Osimertinib (AZD9291) and Necitumumab in EGFR-Mutant Non-Small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors : An Open-label, Non-randomized, Multicenter Phase I Study to Determine the Maximum Tolerated or Recommended Phase II Dose of Oral Mutant IDH1 Inhibitor BAY1436032 and to Characterize Its Safety, Tolerability, Pharmacokinetics and Preliminary Pharmacodynamic and Anti-tumor Activity in Patients With IDH1-R132X-mutant Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma : Phase 1 Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma : A Phase1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line or CUE-101 Combination Therapy With Pembrolizumab in First Line Patients With HPV16+ Recurrent/Metastatic HNSCC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors : A "Window Trial" on Curcumin, the Active Compound in Turmeric, for Invasive Breast Cancer Primary Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM) : An Open-Label, Multicenter Phase 1b Study Investigating the Safety of TAK-079 in Combination With Backbone Regimens for the Treatment of Patients With Newly Diagnosed Multiple Myeloma and for Whom Stem Cell Transplantation Is Not Planned as Initial Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma : Phase 1 Trial of Hu5F9-G4 (Magrolimab) Combined With Dinutuximab in Children and Young Adults With Relapsed and Refractory Neuroblastoma or Relapsed Osteosarcoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
PF-07284892 in Participants With Advanced Solid Tumors : A PHASE 1, OPEN-LABEL, MULTI-CENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY EVIDENCE OF ANTI-TUMOR ACTIVITY OF PF-07284892 (ARRY-558) AS A SINGLE AGENT AND IN COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT : A Phase 1b Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of SER-155 in Adults Undergoing Hematopoietic Stem Cell Transplantation (HSCT) to Reduce the Risk of Infection and Graft vs. Host Disease (GvHD)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[234]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Active, not recruiting
Filter aufheben
Thema: Phase: Phase 1
Medienart
2.334
Aufsätze
2.334
E-Artikel
2.334
E-Ressourcen
Zeitschriftentitel
2.146
ClinicalTrials.gov
188
WHO International Clinical Trials Registry Plat...
Thema
2.334
610
Phase: Phase 1
Recruitment Status: Active, not recruiting
2.334
Study Type: Interventional
307
Neoplasms
194
Carcinoma
193
Lymphoma
145
Leukemia
139
Breast Neoplasms
115
Recurrence
109
Carcinoma, Non-Small-Cell Lung
100
Lung Neoplasms
92
Lymphoma, Non-Hodgkin
88
Melanoma
87
Multiple Myeloma
77
Leukemia, Lymphoid
75
Leukemia, Myeloid
75
Leukemia, Myeloid, Acute
75
Neoplasms, Plasma Cell
67
Leukemia, Lymphocytic, Chronic, B-Cell
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.254
2020-
80
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.332
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...